Retrospective comparison of cyclophosphamide and mycophenolate mofetil in lupus nephritis at Groote Schuur Hospital nephrology unit
Background. Lupus nephritis (LN) can be complicated with requirement for kidney replacement therapy and death. Efficacy of induction therapies using mycophenolate mofetil (MMF) or intravenous cyclophosphamide (IVCYC) has been reported from studies, but there is limited data in Africans comparing bot...
Main Author: | Sogayise, Phelisa |
---|---|
Other Authors: | Okpechi, Ikechi |
Format: | Dissertation |
Language: | English |
Published: |
Faculty of Health Sciences
2021
|
Subjects: | |
Online Access: | http://hdl.handle.net/11427/32991 |
Similar Items
-
Low dose mycophenolate mofetil versus cyclophosphamide in the induction therapy of lupus nephritis in Nepalese population: a randomized control trial
by: Arun Sedhain, et al.
Published: (2018-07-01) -
The Effectiveness and Safety of Mycophenolate Mofetil in Lupus Nephritis
by: Elyan, Mazen
Published: (2008) -
Belimumab and low-doses of mycophenolate mofetil as induction therapy of class IV lupus nephritis: case series and literature review
by: Domenico Paolo Emanuele Margiotta, et al.
Published: (2018-03-01) -
Groote Schuur Hospital Trauma Centre: event and outcome study.
by: Kirsten, Ria
Published: (2011) -
Mycophenolate versus cyclophosphamide for lupus nephritis
by: M Sahay, et al.
Published: (2018-01-01)